Solvay sells North American and European amphoteric surfactants business

The purchase by private equity firm OpenGate Capital includes the company’s three main production sites for amphoterics

Brussels-based science company The Solvay Group has inked a deal to sell its North American and European amphoteric surfactants business to OpenGate Capital, a Los Angeles private equity firm.

The sale includes the three main production sites supporting Solvay’s amphoteric product lines – University Park, Illinois (US), Genthin, Germany and Halifax, UK – as well as a tolling business in Turkey.

The sale, said Solvay, would generate additional resources for it to invest in strategic growth segments as part of its portfolio simplification journey.

Companies